ERBB2 and colorectal carcinoma: In such novel and more complex scenario, a better definition of HER-2 function in CRC has been achieved suggesting its involvement in disease pathogenesis as well as in the emergence of resistance to target therapy [15, 16]: as a result, HER-2 has been regarded as a potential therapeutic target.